Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study

BACKGROUND: Owing to the rarity of this tumor, there is limited information about second‐line chemotherapy for patients with previously treated advanced thymic carcinoma. MATERIAL AND METHODS: We performed a multi‐institutional, retrospective study named NEJ023 for patients with advanced thymic carc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncologist
Asıl Yazarlar: Tateishi, Kazunari, Ko, Ryo, Shukuya, Takehito, Okuma, Yusuke, Watanabe, Satoshi, Kuyama, Shoichi, Murase, Kyoko, Tsukita, Yoko, Ashinuma, Hironori, Nakagawa, Taku, Uematsu, Kazutsugu, Nakao, Mika, Mori, Yoshiaki, Kaira, Kyoichi, Mouri, Atsuto, Miyabayashi, Takao, Sakashita, Hiroyuki, Matsumoto, Yoko, Tanigawa, Tomoyuki, Koizumi, Tomonobu, Morita, Satoshi, Kobayashi, Kunihiko, Nukiwa, Toshihiro, Takahashi, Kazuhisa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Inc. 2019
Konular:
Lung Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160416/
https://ncbi.nlm.nih.gov/pubmed/31771990
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0593
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller